Boothbay Fund Management’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-17,880
| Closed | -$92.3K | – | 1741 |
|
|
2023
Q2 | $92.3K | Sell |
17,880
-17,880
| -50% | -$92.3K | ﹤0.01% | 1405 |
|
|
2023
Q1 | $188K | Hold |
35,760
| – | – | ﹤0.01% | 1526 |
|
|
2022
Q4 | $100K | Sell |
35,760
-11,621
| -25% | -$32.7K | ﹤0.01% | 1543 |
|
|
2022
Q3 | $197K | Buy |
+47,381
| New | +$197K | ﹤0.01% | 1578 |
|
|
2021
Q4 | – | Sell |
-41,466
| Closed | -$415K | – | 1913 |
|
|
2021
Q3 | $415K | Sell |
41,466
-8,459
| -17% | -$84.7K | 0.01% | 972 |
|
|
2021
Q2 | $708K | Buy |
49,925
+7,748
| +18% | +$110K | 0.02% | 735 |
|
|
2021
Q1 | $692K | Sell |
42,177
-26,669
| -39% | -$438K | 0.03% | 621 |
|
|
2020
Q4 | $1.43M | Sell |
68,846
-102,889
| -60% | -$2.13M | 0.05% | 303 |
|
|
2020
Q3 | $1.31M | Sell |
171,735
-78,977
| -32% | -$601K | 0.08% | 291 |
|
|
2020
Q2 | $2.09M | Buy |
250,712
+64,763
| +35% | +$539K | 0.14% | 156 |
|
|
2020
Q1 | $920K | Buy |
185,949
+96,872
| +109% | +$479K | 0.08% | 277 |
|
|
2019
Q4 | $352K | Sell |
89,077
-1,450
| -2% | -$5.73K | 0.03% | 488 |
|
|
2019
Q3 | $275K | Buy |
90,527
+73,966
| +447% | +$225K | 0.03% | 504 |
|
|
2019
Q2 | $73K | Buy |
+16,561
| New | +$73K | 0.01% | 577 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 648 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 700 |
|